降糖药-话题@MedSci

#降糖药#

178篇内容 | 4796人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1270806, encodeId=119b12e080673, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Ann Fam Med：多一勺肉桂，少一片降糖药？, objectType=article, longId=30319, objectId=c9d0303193a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9d0303193a, replyNumber=0, likeNumber=73, createdTime=2014-02-10, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9d0303193a, moduleTitle=Ann Fam Med：多一勺肉桂，少一片降糖药？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9d0303193a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270805, encodeId=d89212e0805a1, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=安斯泰来降糖药Suglat获日本批准, objectType=article, longId=29655, objectId=fb822965599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb822965599, replyNumber=0, likeNumber=61, createdTime=2014-01-22, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb822965599, moduleTitle=安斯泰来降糖药Suglat获日本批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb822965599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270804, encodeId=c8ab12e08044e, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=2型糖尿病合并慢性肾脏病患者口服降糖药用药原则中国专家共识, objectType=article, longId=29178, objectId=74fb291e85c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74fb291e85c, replyNumber=0, likeNumber=67, createdTime=2014-01-11, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74fb291e85c, moduleTitle=2型糖尿病合并慢性肾脏病患者口服降糖药用药原则中国专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74fb291e85c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270803, encodeId=1ccc12e080393, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Nature：新型降糖药物问世, objectType=article, longId=28470, objectId=bc5b284e078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc5b284e078, replyNumber=0, likeNumber=73, createdTime=2013-12-25, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc5b284e078, moduleTitle=Nature：新型降糖药物问世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc5b284e078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270802, encodeId=8b2612e0802ef, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=诺和诺德降糖药Ryzodeg达非劣效性终点, objectType=article, longId=27672, objectId=0ab72e67255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ab72e67255, replyNumber=0, likeNumber=72, createdTime=2013-12-08, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ab72e67255, moduleTitle=诺和诺德降糖药Ryzodeg达非劣效性终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ab72e67255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270801, encodeId=aca912e0801c3, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=朱大龙：GLP-1降糖药物的临床应用共识, objectType=article, longId=27158, objectId=0d702e158ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d702e158ff, replyNumber=0, likeNumber=78, createdTime=2013-11-28, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d702e158ff, moduleTitle=朱大龙：GLP-1降糖药物的临床应用共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d702e158ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270800, encodeId=f33812e080055, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=CDS 2013：杨文英认为DPP-4抑制剂是“智能化”降糖药, objectType=article, longId=27157, objectId=fec72e15705, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fec72e15705, replyNumber=0, likeNumber=84, createdTime=2013-11-28, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fec72e15705, moduleTitle=CDS 2013：杨文英认为DPP-4抑制剂是“智能化”降糖药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fec72e15705)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270799, encodeId=0cae12e079958, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=NEJM：降糖药沙格列汀无心血管保护作用, objectType=article, longId=24023, objectId=994e24023b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=994e24023b1, replyNumber=0, likeNumber=88, createdTime=2013-09-08, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=994e24023b1, moduleTitle=NEJM：降糖药沙格列汀无心血管保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=994e24023b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270798, encodeId=842d12e079836, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=安进终止降糖药AMG 151临床开发, objectType=article, longId=22810, objectId=e38a22810d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e38a22810d4, replyNumber=0, likeNumber=82, createdTime=2013-08-10, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e38a22810d4, moduleTitle=安进终止降糖药AMG 151临床开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e38a22810d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270797, encodeId=71aa12e079744, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=FDA推迟审查葛兰素史克GLP-1类降糖药albiglutide, objectType=article, longId=22663, objectId=12a522663c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12a522663c9, replyNumber=0, likeNumber=64, createdTime=2013-08-07, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12a522663c9, moduleTitle=FDA推迟审查葛兰素史克GLP-1类降糖药albiglutide, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12a522663c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270796, encodeId=827212e079647, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=AJG：降糖药与胰腺癌发病风险的关系尚不明确, objectType=article, longId=19403, objectId=de4119403c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de4119403c2, replyNumber=0, likeNumber=68, createdTime=2013-05-30, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de4119403c2, moduleTitle=AJG：降糖药与胰腺癌发病风险的关系尚不明确, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de4119403c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270795, encodeId=77bf12e07955d, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes：降糖药linagliptin可能减少中风后脑损伤, objectType=article, longId=18281, objectId=788218281fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788218281fd, replyNumber=0, likeNumber=88, createdTime=2013-05-08, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788218281fd, moduleTitle=Diabetes：降糖药linagliptin可能减少中风后脑损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788218281fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270794, encodeId=528d12e0794a0, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Am J Kidney Dls：降糖药物或使肾病透析患者获益, objectType=article, longId=15035, objectId=15bc15035a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15bc15035a2, replyNumber=0, likeNumber=84, createdTime=2013-02-03, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15bc15035a2, moduleTitle=Am J Kidney Dls：降糖药物或使肾病透析患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15bc15035a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270793, encodeId=5dba12e079376, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes:新型降糖药或可减少卒中后脑损伤, objectType=article, longId=12876, objectId=49e3128e697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49e3128e697, replyNumber=0, likeNumber=75, createdTime=2012-12-12, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49e3128e697, moduleTitle=Diabetes:新型降糖药或可减少卒中后脑损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49e3128e697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270792, encodeId=05d812e07928e, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=指南解读：2012瑞典内分泌学和糖尿病学会治疗建议-降糖药物和肾病, objectType=article, longId=11248, objectId=d42a112489a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d42a112489a, replyNumber=0, likeNumber=72, createdTime=2012-11-25, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d42a112489a, moduleTitle=指南解读：2012瑞典内分泌学和糖尿病学会治疗建议-降糖药物和肾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d42a112489a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270791, encodeId=293b12e079185, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Plos One：我国应用降糖药的糖尿病患者不足一半, objectType=article, longId=10871, objectId=b176108e141, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b176108e141, replyNumber=0, likeNumber=69, createdTime=2012-11-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b176108e141, moduleTitle=Plos One：我国应用降糖药的糖尿病患者不足一半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b176108e141)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270790, encodeId=166312e079040, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=EASD2012：中国口服降糖药应用状况堪忧, objectType=article, longId=10572, objectId=e070105e2bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e070105e2bb, replyNumber=0, likeNumber=110, createdTime=2012-10-26, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e070105e2bb, moduleTitle=EASD2012：中国口服降糖药应用状况堪忧, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e070105e2bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270789, encodeId=396012e0789fc, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=降糖药吡格列酮或面临限制使用, objectType=article, longId=9178, objectId=397791e8b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=397791e8b7, replyNumber=0, likeNumber=80, createdTime=2012-08-23, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=397791e8b7, moduleTitle=降糖药吡格列酮或面临限制使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=397791e8b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270788, encodeId=fd5212e07884b, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Kidney Int：磺脲类降糖药更易导致肾脏不良事件的发生, objectType=article, longId=8794, objectId=5e698e9434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e698e9434, replyNumber=0, likeNumber=89, createdTime=2012-08-11, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e698e9434, moduleTitle=Kidney Int：磺脲类降糖药更易导致肾脏不良事件的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e698e9434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270787, encodeId=75cc12e07873a, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=T2DM患者口服降糖药失效后应尽快胰岛素治疗, objectType=article, longId=8699, objectId=16838699fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16838699fe, replyNumber=0, likeNumber=70, createdTime=2012-08-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16838699fe, moduleTitle=T2DM患者口服降糖药失效后应尽快胰岛素治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16838699fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

降糖药

2020-05-29

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Ann Fam Med：多一勺肉桂，少一片降糖药？

2014-02-10

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

安斯泰来降糖药Suglat获日本批准

2014-01-22

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

2型糖尿病合并慢性肾脏病患者口服降糖药用药原则中国专家共识

2014-01-11

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Nature：新型降糖药物问世

2013-12-25

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

诺和诺德降糖药Ryzodeg达非劣效性终点

2013-12-08

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

朱大龙：GLP-1降糖药物的临床应用共识

2013-11-28

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

CDS 2013：杨文英认为DPP-4抑制剂是“智能化”降糖药

2013-11-28

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

NEJM：降糖药沙格列汀无心血管保护作用

2013-09-08

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

安进终止降糖药AMG 151临床开发

2013-08-10

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

FDA推迟审查葛兰素史克GLP-1类降糖药albiglutide

2013-08-07

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

AJG：降糖药与胰腺癌发病风险的关系尚不明确

2013-05-30

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes：降糖药linagliptin可能减少中风后脑损伤

2013-05-08

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Am J Kidney Dls：降糖药物或使肾病透析患者获益

2013-02-03

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes:新型降糖药或可减少卒中后脑损伤

2012-12-12

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

指南解读：2012瑞典内分泌学和糖尿病学会治疗建议-降糖药物和肾病

2012-11-25

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Plos One：我国应用降糖药的糖尿病患者不足一半

2012-11-09

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

EASD2012：中国口服降糖药应用状况堪忧

2012-10-26

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

降糖药吡格列酮或面临限制使用

2012-08-23

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Kidney Int：磺脲类降糖药更易导致肾脏不良事件的发生

2012-08-11

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

T2DM患者口服降糖药失效后应尽快胰岛素治疗

2012-08-09

科室
- - 订阅+
  - 更多科室
工具
服务